In contrast to neurodegerative disorders and cancer, the contribution of TG2 activity to celiac sprue pathogenesis has been pretty effectively set up. The deamidation of certain glutamine residues focused by TG2 in gluten peptides continues to be shown to enhance peptide binding to the disease-relat